Human immunodeficiency virus (HIV-1) infection in the human brain Ieads to characteristic neuropathological changes, which may result indirectly from interactions of the envelope glycoprotein gp 120 with neurons and/or glial cells. We therefore investigated the binding of recombinant gp120 (rgp120) to human neural cells and its effect on int~acellular.s.ignallin~. Herewe pre~ent evidence that rgp120, besides binding to galactocerebroside or galactosyl-sulfatlde, spec1f1cally bmds to a protem receptor of a relative molecular mass of approximately 180,000 Da (180 kDa) pre~ent. on the CD4-negative glioma cells D-54, but not on Molt4 T lymphocytes. Binding of rgp120 to this receptor rap1dly 1nduced a tyrosine-specific protein kinase activity leading to tyrosine phosphorylation of 130-and 115-kDa p~oteins. The c~ncentration of intracellular calciumwas not affected by rgp120 in these cells. Our data suggest a novel Signal transduc1ng HIV-1 gp120 receptor on CD4-negative glial cells, which may contribute to the neuropathological changes observed in HIV-1-infected brains.
INTRODUCTION
Neuropathological changes in the central nervaus system (CNS) of AIDS patients, which Iead to the socalled AIDSdementia complex (ADC), are of great clinical importance. Manifestations of ADC are progressive cognitive, motor, and behavioral dysfunctions that have been linked to the persistence of HIV-1 infections in the CNS and are mainly found in CD4-positive (CD4+) microglial cells and circulating macrophages (Budka, 1991; Fauci, 1988; Jordan et al., 1991; Ketzler et al., 1990; Liu et al., 1990; Maddon et al., 1986; McArthur, 1987; Merrill and Chen, 1991; Price et al., 1988) . However, in the absence of CD4 molecules on the cell membrane of the majority of brain cells and in the light of the paucity of direct evidence for HIV infection of neurons and glial cells it has been suggested that the HIV-associated degenerative neurological abnormalities are the result of indirect mechanisms mediated by soluble factors of viral or cellular origin (Brenneman et a/., 1988; Dreyer et al., 1990; Giulian et al., 1990; Kaiser et al., 1990; Pulliam et al., 1991; Wahl et al., 1991 ) . These factors could be cytotoxic to Subpopulations of brain cells or interfere with neuronal and glial cell functions leading to neurodegeneration.
One such factor, the HIV-1 envelope glycoprotein gp120, which is easily shed from infected cells, has been studied in the past. lt was found that gp 120 does not only bind to the well-known CD4 molecules, but also to galactocerebroside (GaiC} and galactosyl-sulfatide, cellular membrane components expressed on the surface of oligodendrocytes and other neural cells (Harouse et al., 1991; Kuhlmann-Krieg et al., 1988; Ranscht et al., 1982) . Polyclonal antibodies to GaiC can inhibit the entry of HIV-1 in neural celllines, suggesting that the binding of HIV to these membrane structures might be of biological significance Harouse et al., 1991) . However, to mediate signals possibly leading to cellular dysfunction, entry of viruses into cells is not necessary, but rather the interaction of HIV-1 or gp 120 with cell surface receptors may be sufficient. lndeed, it was found that treatment of neuronal cultures of rodents with gp120 tagether with exitatory amino acids resulted in marked increases of intracellularcalcium and ultimately in neuronal cell death (Brenneman et al., 1988; Choi, 1988; Dreyer et al., 1990; Kaiser et al., 1990; Lipton et al., 1991 ) . Theseobservations give certainly support to the hypothesis that soluble HIV-1 gp120 may interfere not only with neuronal, but also with glial cell functions and may be associated with the development of ADC.
To study the effect of HIV-1 gp120 on human brain cells, we used the human glioma cellline D-54, which does not express CD4 molecules. lnvestigation of these cells revealed high-affinity binding of rgp 1 20 to a novel trypsin-sensitive receptor. Binding of gp120 to these cells was leading to a tyrosine phosphorylation of 130 and 11 5 kDa proteins in the absence of any increase of intracellular Ca 2 +. These data prove that binding of a HIV-1 structural protein alone to cell membrane molecules Ieads to signal transduction, which could be of pathogenetic significance.
MATERIALS AND METHODS

Culture of cells
The human malignant glioma cell lines D-54 and U-373 (Bigner et al., 1981) were cultured in Dulbecco's minimal essential medium (DMEM) containing Streptomycin (1 00 ~g/ml}, penicillin (1 00 U/ml), and 5% fetal calf serum (FCS) at 37° and 10% C0 2 • The CD4+ T lymphocytic cells Molt4, H9 and C8166, and the CD4-B lymphocytic cells BJAB were cultured in Roswell Park Memorialinstitute (RPMI) 1640 medium containing the same additives.
Polymerase chain reaction
For PCR, 10 5 cells were infected with HIV-1 (HTLV-1118, a kind gift of R. Gallo; m.o.i. = 1 ). After 15 days (three passages), DNA was prepared and virus-specific DNA amplified with the gag-specific primers SK38 and SK39 and Taq-polymerase (8oehringer-Mannheim) as described (Ou et al., 1988) . DNA was separated on a 1 5% polyacrylamide gel and blotted on nitrocellulose. After hybridization with the end-labeled 41-bp fragment SK19 of HIV-1, filters were exposed to X-ray films (DuPont).
Preparation of RNA and Northern blot
Total cellular RNA was prepared as described (Chirgwin et al., 1979) . Poly-A+-RNA was selected on oligo-dT-cellulose (Sigma). Eight micrograms of poly-A+-RNA per lane was separated on 1.5% agarase gels containing 6.3% formaldehyde and blotted on Hybond N filters (Amersham) by diffusion. As hybridization probes the 0.6-kb EcoRI/Sacl fragment of CD4-cDNA of plasmid T4-pMV6tklneo (a gift of Dr. D. R. Littman, Columbia University, New York) and the 1.3-kb Pstl fragment of a plasmid containing the rat glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA were labeled with [ 32 P]dCTP with a random-primed labeling kit (Boehringer-Mannheim).
lmmunofluorescent staining and flow cytometry
To quantify surface molecule expression by flow cytometry, cells were harvested with Ca 2 +-and Mg 2 + -free PBS. To partially remove surface proteins, 2 X 10 5 cells/tube were incubated with 1 ml 0.1% trypsin in P8S for 10 min at room temperature, centrifuged, the supernatant aspirated, and washed once with 1 ml medium containing 1 0% FCS and two times with 1 ml Ca 2 +-and Mg 2 +-free PBS containing 0.2% BSA (FACS-buffer). For rgp120-binding studies, cells were incubated with 200 ~I 1 JLg/ml rgp120 (strain 1118; MRC Directed AIDS Programme) for 1 hr on ice, washed three times with FACS-buffer and stained with antigp 120 and FITC-conjugated second antibodies. The following monoclonal antibodies (mAbs) were used: mause lgG, (Dako) as negative control; anti-CD4 mAb OKT4 (Ortho Diagnostics); anti-MHC class I mAb W6/ 32; anti-GaiC mAb (Boehringer-Mannheim); anti-galactosyl-sulfatide mAb 04 (a gift of M. Schachner, ETHZUrich, Switzerland); anti-gp120 mAb (DuPont); FITCconjugated rabbit anti-mouse lg mAb (Dako).
Labeling of rgp120 with 125 1 and binding studies
Labeling of rgp120 (strain 1118; MRC Directed AIDS Programme) was performed by lactoperoxidase with single-reaction enzymobead radioiodination reagent (Bio-Rad). rgp120 (5 JL9) in 75 ~I 0.2 M phosphate buffer, pH 7.2, 25 ~I containing 1.0 mCi Na 125 1 (Amersham) and 25 ~I containing 1% beta-o-glucose, were added to 50 ~I rehydrated enzymobead reagent. The reaction mixturewas incubated for 25 min at room temperature, directly applied to a gel filtration column (Sephadex-G25), and eluted with PBS into ice-cold tubes. Binding studies were performed with fractions containing rgp120 labeled to a specific activity of approximately 1 200 cpm/pmol in 5 ml PBS containing 0.5% BSA for 2 hr at 4°. Cells were washed three times quickly with ice cold PBS 0.5% BSA and cell-bound radioactivity and supernatants counted in a gammacounter (LK8).
Chemical crosslinks
For crosslinking 5 x 1 0 6 cells were harvested with Ca 2 +-and Mg 2 +-free PBS and incubated for 2 hr on ice with 0.1 ~g [ 125 1]rgp120 in 100 ~1. After washing four times with PBS, cells were resuspended in 1 00 ~I P8S. The crosslinkers disuccinimidyl-suberate (DSS, stock: 50 mM in DMSO, Pierce) and bis-(sulfosuccinimidyl}-suberate (BS 3 , stock: 50 mM in PBS, Pierce) were added to final concentrations of 0.2 mM, 1 mM, and 5 mM, and the suspensions incubated 1 hr at room temperature. Cells were lysed by addition of 1 volume Iysis buffer (1% Triton X-1 00, 1% Na-deoxycholate, 0.1 o/o SOS, 150 mM NaCI, 10 mMTris-HCI, pH 7.4, 0.1 mM PMSF), and centrifuged for 10 min at 10,000 g. Supernatants were separated by polyacrylamide gel electrophoresis with 6% sodium dodecylsulfate (SOS-PAGE) and dried gels exposed to X-ray films (DuPont) for 7 days. for 1 hr at 36°, the cells were washed twice and resuspended in buffer A. Assays were carried out at 32° with a modified 4-8202 Aminco-Bowman spectrofluorimeter (Silver Spring, MD) fitted with a magnetic stirrer and a thermostated cuvette holder. lntracellular fura-2 fluorescence intensity was measured at two excitation wavelengths (340 and 385 nm) and continuously recorded at 500 nm. Cells were treated with 0.01-1.0 p.g/ml rgp120 and for control with 10 U/ml thrombin (Sigma). At the end of each individual trace, cells were permeabilized with 0.1% Triton X-1 00 to yield the fluorescence signals of high Ca 2 +. Then 8 mM EGTN50 mMTris was added to give the fluorescence signals for minimal Ca 2 + concentration (<1 nm). Ca 2 + values were calculated according to the equation given in Grynkiewicz et al. (1985) using the 340/385 nm ratio of fluorescence intensities and the Ca 2 + -dye dissociation constant (Kd = 224 nM).
Detection of phosphotyrosine by Western blot
Todetermine tyrosine phosphorylation, 5 x 10 5 cells were incubated with rgp120 in 1 ml complete culture medium, aspirated and dissolved in 300 p.llysis buffer (200 p.l PBS plus 100 p.l 200 mM Tris-HCI, pH 6.8, 5% SDS, 15% glycerol, 10% ß-mercapto ethanol, 0.01% bromophenol blue), and applied to 8% SOS-PAGE (1 00 JLg/lane). A semidry Western blot on nitrocellulose filters (Schleicher & SchOll) was performed as described (Kyhse-Andersen, 1 984) and the background blocked with 1% BSA and 1% gelatine in TNA (1 0 mM Tris-HCI, pH 7.2, 150 mM NaCI, 0.01% NaN 3 ) overnight. Anti-phosphotyrosine monotonal antibody PY20 (ICN Flow) diluted 1 : 1 000 in blocking buffer was applied for 2 hr. After washing for 3 x 5 min with TNA and 5 min with TNA containing 0.05% NP-40, filters were incubated with 125 1-labeled anti-mause lgG (Amersham) diluted 1 :350 in blocking buffer for 2 hr. Filters were washed 6 x 1 0 min with TNA and overnight with TNA containing 0.05% NP-40 and exposed to X-ray films (DuPont). Sodium orthovanadate (20 JLM) was present in all solutions.
RESULTS
The human glioma cellline D-54 is CD4-negative For our studies on rgp 120-cell interactions we selected D-54 glioma cells, because these cells are highly responsive to external stimuli like cAMP-analogs (Bigner et al., 1981) and might therefore be good candidates to investigate signal transduction. We first assessed these cells for susceptibility to HIV-1 and presence of CD4 molecules. Like the neuronal cell lines SK-N-BE and IMR-32 and the glioblastoma line U-373 (Li et al., 1990; Harouse.et al., 1989}, we found that the glioblastoma line 0-54 was nonproductively infected with HIV-1. ln the absence of production of infectious virus and the development of a cytopathogenic effect (CPE), HIV-1-specific DNA could be detected in D-54 cells by polymerase chain reaction (Fig. 1 A) as weil as p24 core antigen, although these cells did not contain CD4-specific mRNA or truncated RNAs (Fig. 18) . ln addition, we confirmed by immunofluorescent staining and flow cytometry that these cells, in cantrast to the T cell line Molt4, did not express CD4 on their surfaces ( Fig. 2A, 28) . Obviously, binding and entry of HIV-1 into D-54 cells occured by a CD4-independent mechanism.
D-54 glioma cells express galactosyl-sulfatide
GaiC and galactosyl-sulfatide have been found to bind HIV-1 gp120 as purified substances and on the surface of neural cells Harouse et al., 1991 ) . Therefore, we determined the expression of GaiC and galactosyl-sulfatide on D-54 cells by immunofluorescent staining with monoclonal antibodies and flow cytometry. D-54 cells were not stained with antibadies to GaiC, but expressed galactosyl-sulfatide on their surfaces (Fig. 2C) . As control we stained U-373 cells, which expressed GaiC and galactosyl-sulfatide (Fig. 20) . We now investigated whether galactosyl-sulfatide is the only molecule on D-54 cells capable of binding gp120, or if a further class of binding sites might be expressed on these cells.
Binding of rgp120 to cell surfaces
To roughly estimate the amount of purified CHO cellderived recombinant gp120 of HIV-1 (strain 1118) capable of binding toD-54 cells, we first used immunofluorescent staining methods and analysis by flow cytometry. After stringent washing, low, but significant Ievels of rgp120 binding to 0-54 cells remained detectable, when compared to CD4+ Molt4 cells (Fig. 2E, 2F ). ln addition, we made the interesting observation that the specific binding of rgp120 was decreased after treatment of both celllines with trypsin (Fig. 2E, 2F ). Since galactosyl-sulfatide is not sensitive to trypsin, these results suggested the presence of a proteinaus receptor for gp 1 20 on the surface of D-54 cells.
Todetermine the exact binding properties of rgp120 to D-54 cells, rgp120 was labeled with 126 1odine (Fig .  3A) . The affinity constant for the rgp120-D-54 cell interaction was assessed by whole cell binding assays. Providing 126 1-labeled rgp120 up to a concentration of 100 nM, we could not reach the Ievei of saturation (Fig.  38 ), but the binding of 125 1-labeled rgp120 (400 fM/1 0 6 cells) was specifically inhibited by 50o/o with approximately 20 nM unlabeled rgp120 (not shown). Intermediate saturation of high-affinity binding sites of rgp1 20 on D-54 cells was detected already at a free concentration of 300 to 500 fM rgp1 20, whereas at higher concentrations low-affinity binding increased. Scatchard analysis of these data revealed binding sites with a dissociation constant (Kd) of approximately 1 .2 X 1 o-10 M for high-affinity and 3.2 X 1o-9 M for low-affinity binding sites (Fig. 3C) . The abundance of receptor sites on D-54 cells was determined to be approximately 7 x 1 0 4 /cell for high affinity receptors and more than 1 0 6 /cell for lower affinity receptors (average of eight experiments). The flow cytometry data suggest that at least one of these receptors is trypsin sensitive and therefore of proteinaus nature, whereas the other is likely to be galactosyl-sulfatide.
Crosslinking of rgp120 to cell surface molecules To investigate the nature of the trypsin-sensitive gp120 receptors on D-54 cells, we performed crosslinking experiments with several chemical crosslinkers. Using the crosslinkers disuccinimidyl suberate (DSS) and bis(sulfosuccinimidyl) suberate (88 3 ), we detected one labeled ligand-receptor complex at approximately 300 kDa with D-54 cells, but not with Molt4 cells (Fig.  4) . The intensity of this 300-kDa band (Fig. 4, lanes  3-8) was relatively low, as compared to cross-linked CD4 molecules on the surface of Molt4 cells (Fig. 4,  lanes 9-11 ) . lncreasing concentrations of cross-linkers led to high molecular weight complexes with D-54 and Molt4 surface molecules on top of the gel (Fig. 4, lanes  5, 8, 11 }. The 300-kDa complex is unlikely to consist of cross-linked rgp120 molecules itselves, since we did not observe bands of dimerized gp120 with a molecu- 14 C-Iabeled marker proteins had molecular masses of 200 kDa and 97.4 kDa (lanes 1 and 12) . 126 1-labeled rgp120 was incubated with D-54 cells (lanes 2-8) and with Molt4 cells (lanes 9-11 ). lncubation of D-54 with 126 1-labeled rgp 120 in the absence of crosslinker (lane 2) did not Iead to higher molecular weight complexes. lncreasing concentrations (0.2 mM, 1 mM, 5 mM) of the cross-linkers disuccinimidyl suberate (DSS) (lanes 3-5 and 9-11) and bis(sulfosuccinimidyl) substrate (BS 3 ) (lanes 6-8) led to one ligand-receptor complex with an approximate relative molecular mass of 300 kDa (lanes 3-8) . The crosslink of the CD4 molecule (60 kDa) on Molt4 cells with rgp 120 was used as positive control giving a complex of 180 kDa (lanes 9-11 ). A diffuse band of approximately 240 kDa was also seen with Molt4 cells, which is likely to consist of the dimerization product of rgp 120. Unspecific high molecular weight complexes at the top of the gel accumulated with increasing concentrations of crosslinkers (lanes 5, 8, 11 ).
band at 240 kD, probably the dimerization product of rgp120. Therefore, the 300-kDa complex observed with D-54 cells is likely to consist of 126 1-labeled rgp120 cross-linked to a single 180-kDa molecule. Taken together, these data indicate that a trypsin-sensitive 180-kDa cell surface protein might be a high-affinity receptor for gp120.
Determination of intracellular calcium concentrations
Recent reports on the neurotoxicity of gp 120 in cell culture suggested that signal transduction through an unknown surface molecule may disturb cellular tunetians by raising intracellular Ca 2 + concentrations ( Brenneman et al., 1988; Dreyer et al., 1990; Kaiser et al., 1990; Pulliam et al., 1991 ) . When we measured intracellular Ca 2 + concentrations in D-54 cells in response to 0.01 to 1 J.Lg/ml rgp120, no increase of Ca 2 + Ieveis could be detected (Fig. 5A ). As control, we measured a high response of Ca 2 + increase after treatment of cells with 10 U/ml thrombin (Fig. 58}, ionomycin and Triton X-1 00 (not shown). Thus, intracellular Ca 2 + concentrations were not affected by rgp 120 in D-54 cells.
Activation of tyrosine phosphorylation by rgp 120
Assessing a different signal transduction pathway, namely the activation of cellular tyrosine kinases, we observed a rapid induction of tyrosine phosphorylation of proteins after interaction of rgp 120 with 0-54 cells (Fig. 6) . The phosphotyrosine-specific antibody used in this Western blot detected a predominant molecular species at 130 kDa and a minor band at 115 kDa after ca+i .-----------. (Fig. 6, lanes 4-6) . Maximal tyrosine phosphorylation was found already 0.5 to 1.0 minutes after treatment of D-54 cells with rgp 120. ln contrast, the lymphocytic cells Molt4 (Fig. 6, lanes 7-1 0) and BJAB (not shown) did not reveal tyrosine phosphorylation in response to rgp120. Tyrosine phosphorylation was also not observed after treatment of D-54 cells with antibodies to galactosyl sulfatide (not shown). lnduction of tyrosine phosphorylation was completely abolished by pretreatment of the cells with trypsin (Fig. 6,  lanes 11, 12) , indicating that trypsin-sensitive cell surface proteins are essential for transmission of the signal.
DISCUSSION
Our results indicate that a surface molecule of approximately 180 kDa expressed on the surface of the human glioma cells D-54 might be a novel receptor for gp120, which transduces either itself, or as a receptor complex, a signal leading to tyrosine phosphorylation of two proteins with molecular masses of 130 and 115 kDa. The human glioma cells did not express the main HIV-1 receptor CD4 as mRNA or as protein on their surfaces.lt has been described that several CD4-cells are susceptible to HIV-1, implicating the existence of additional HIV-1 receptors on neural cells (Ciapham et al., 1989; Harouse et al., 1989 Harouse et al., , 1991 Kozlowski et al., 1991; Li et al., 1990; Mizrachi et al., 1991; Schmitt et al., 1990) . The only known molecular species expressed on the surface of D-54 cells capable of binding gp120 was found to be galactosyl-sulfatide. A similar molecule, GaiC, has been described to bind rgp120 with an affinity of 1.16 x 1 o-10 M (Harouse et al., 1991) , which is higher than the affinity of rgp 1 20 binding to CD4 (2-5 x 1 o-s M; Lasky et al., 1987) . We found that D-54 cells express two classes of binding sites with higher (1.2 x 1 o-10 M) and lower (3.2 x 1o-9 M) affinity to rgp120. When compared with the results of Harouse et al. ( 1991) , our affinity data suggest that the high er affinity receptors consist of galactosyl-sulfatide and the lower affinity receptors of the trypsin-sensitive cell surface proteins. We also determined the binding of rgp 120 to trypsin-treated D-54 cells. But the resulting values of the binding assays were partially high er than of untreated cells and could not be evaluated properly. A possible explanation for these results could be that galactosyl-sulfatide epitopes are unmasked by the treatment with trypsin and led to higher binding values.
By chemical cross-linking of 125 1-labeled rgp 120 to cell surface molecules we detected one ligand-receptor complex of approximately 300 kDa. The crosslinkers 088 and 88 3 do not link Iipids like galactosylsulfatide to proteins, since reactive amino groups are missing. Therefore, the 300-kDa complex cross-linked by D88 and 88 3 is likely to consist of rgp 120 and the trypsin-sensitive cell surface component binding rgp120. 8ince no smaller complexes of dimerization products or complexes of degradation products of rgp120 were detected with D-54 cells, it is likely that a single molecular species of approximately 180 kDa was cross-linked to rgp120. The low intensity of the cross-linked complex in comparison to the CD4-rgp120 complex on Molt4 cells is astonishing, since the number of CD4 molecules per cell is similar to the number of high-affinity receptors and less than the number of lower affinity receptors on 0-54 cells. Because of the low intensity, one could suppose that the protein receptor corresponds to the lower abundance, higher affinity class of binding sites. However, one reason for the low intensity of the cross-linked complex could be that cross-linking of rgp120 with the protein receptor with lower affinity to gp120 is competed by the higher affinity binding of rgp 1 20 to galactosyl-sulfatide on the surface of 0-54 cells.
lt was found that antibodies to the membrane Iipid GaiC can induce an increase of intracellular Ca 2 + concentrations in oligodendrocytes, but only after treatment of cells with very high concentrations of antibodies (~4 70 ~g/ml; Dyer and Benjamins, 1 990). We did not detect any increase of intracellular Ca 2 + in response to rgp 120 in D-54 cells. The signal transduction pathway of the observed tyrosine phosphorylation is clearly of a different nature, since antibodies to galactosyl-sulfatide did not Iead to tyrosine phosphorylation, and treatment of cell surfaces with trypsin abolished the transduced phosphorylation signal. The tyrosine-phosphorylated 130-and 11 5-kDa proteins might be subunits of a receptor complex with the crosslinked 180-kDa rgp120-binding molecule. However, it is not possible to clearly judge whether phosphorylation is inter-or intramolecular based on the rapid kinetic of tyrosine phosphorylation in intact cells. Our control using CD4 + Molt4 cells did not reveal induction of tyrosine phosphorylation in response to rgp 120, which is in accordance with the results of Horak et al. (1990) forT lymphocytes. Tyrosine phosphorylation of proteins with molecular masses in the range of 110 to 140 kDa has been described to occur after activation of many cell surface receptors on brain cells including receptors for neurotrophic factors (Soppet et al., 1991; Squinto et al., 1991 ) , the interleukin-6 receptor (Hibi et al., 1990) , and receptors of the integrin family (Kornberg et a/., 1991 ). lt will be of great interest to identify the nature of the receptor complex we found and the tyrosine kinase involved.
Programmed cell death or apoptosis is a physiological mechanism involved in normal tissue turnover during embryogenesis and adult life, especially in the brain, bone marrow and thymus (McConkey et al., 1990) . ln AIDS patients, this mechanism has been suggested to be responsible forT helper cell depletion (Ameisen and Caprone, 1 991) and could also cause cellular dysfunction and atrophy as observed in the brain (Fauci, 1988) . ln addition, the HIV envelope glycoprotein gp 120 has been shown to increase intracellular Ca 2 + concentrations tagether with NMDA receptor agonists and to injure rodent neurons in vitro (Brenneman et al., 1988; Dreyer et al., 1990; Lipton et al., 1991 ) . These mechanisms and the observed tyrosine phosphorylation in response to rgp120 in glial cells could provide a combination of signals leading to astrocytosis, impairment of myelin, and neurodegeneration as found in brains of AIDS patients. Further experiments are required to investigate the pathogenetic significance of this tyrosine kinase signal transduction pathway in neuro-AIDS.
